SCHEMBL12410039

SCHEMBL12410039

CN(C)c1nc2ccccc2nc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.58
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
KDM4E B2RXH2 4/20 0.45
PKM P14618 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
GAA P10253 1/20 0.42
ATM Q13315 1/20 0.41
NCF1 P14598 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
TSHR P16473 3/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327853 0.80 KMT2A (0.51) TDP1KMT2AMEN1KDM4EPKM
SCHEMBL29451077 0.75 TDP1 (1.00) TDP1KMT2AMEN1KDM4EPKM
SCHEMBL116696 0.75 TDP1 (1.00) TDP1KMT2AMEN1KDM4EPKM
SCHEMBL11275692 0.75 KMT2A (0.47) TDP1KMT2AMEN1SMN1; SMN2MAPT
SCHEMBL18240399 0.75 ALDH1A1 (0.54) TDP1KMT2AMEN1KDM4EL3MBTL1
SCHEMBL15647185 0.75 ALDH1A1 (0.54) TDP1KMT2AMEN1KDM4EL3MBTL1
SCHEMBL1811989 0.74 TDP1 (0.44) TDP1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL14385535 0.71 KMT2A (0.43) TDP1KMT2AMEN1KDM4EPKM
SCHEMBL1670942 0.70 TDP1 (0.67) TDP1KMT2AMEN1KDM4EPKM
SCHEMBL1084629 0.69 EGFR (0.59) TDP1KMT2AMEN1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342191-B1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORP (JP) 2013-03-20 EP disclosed
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-07-07 US disclosed
WO-2010030027-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE PDE10A, PDE3A, PDE3B TDP1 998/4885KMT2A 2102/4885MEN1 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.